Hyperparathyroidism : The Lancet

Links shared publicly online about this topic.

  • 1,907
    total visits

Hyperparathyroidism : The Lancet

thelancet.com

Hyperparathyroidism. By - Prof William D Fraser MD

View full resource at thelancet.com

Tags: Parathyroid Disorder

  • Share

Most Recently Shared on July 10, 2009 at 9:31 pm By:

Infections Cause Many Cancers Globally

medicalnewstoday.com — “A new study published Online First in The Lancet Oncology reveals that from 7.5 million cancer deaths in 2008, about 1.5 million were due to infections that could have either been preveView full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on May 11, 2012 at 7:05 pm By:

Can Getting Sick Give You Cancer? New Research Says Sometimes, Yes - Forbes

forbes.com — “One sixth of all cases of cancer are caused by viruses and bacteria, new research says. Meaning they're preventable! If we know how.View full resource at forbes.com

  • View Related
  • Share

Most Recently Shared on May 11, 2012 at 12:13 am By:

Protecting Against Serogroup B Meningococcal Strains - New Vaccine Shows Promise

medicalnewstoday.com — “Serogroup B meningococcal strains have become the major cause of bacterial meningitis in many European and North American regions. A new study published Online First in The Lancet InfectiouView full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on May 10, 2012 at 7:05 pm By:

mnt_vaccines MNT Vaccines Health News

Protecting Against Serogroup B Meningococcal Strains - New Vaccine Shows Promise http://t.co/gCbKWw2t #vaccines #immunesystem

3 weeks ago...

Infection Behind One Sixth Of Cancers Worldwide

medicalnewstoday.com — “Around 2 million, or one sixth of new cancer cases worldwide are due to infections that are largely preventable or treatable, says a landmark study published in The Lancet OncologyView full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on May 9, 2012 at 4:05 pm By:

Increased Risk of Primary Hyperparathyroidism in Celiac Disease - Celiac.com

celiac.com — “People with celiac disease face a higher risk of developing primary hyperparathyroidism (PHPT) in the early years after their celiac disease is diagnosed, according to a new report from Sweden. The report appears in the The Journal of Clinical Endocrinology & Metabolism.View full resource at celiac.com

  • View Related
  • Share

Most Recently Shared on May 7, 2012 at 9:16 am By:

csaceliacs csaceliacs Health Organization

Increased Risk of Primary Hyperparathyroidism in Celiac Disease - http://t.co/2y1rcrPk http://t.co/60tBoHLI #GF #Celiac

4 weeks ago...

Point-of-care genetic testing for personalisation of antiplatelet treatment (RAPID GENE): a prospective, randomised, proof-of-concept trial : The Lancet

thelancet.com — “Point-of-care genetic testing for personalisation of antiplatelet treatment (RAPID GENE): a prospective, randomised, proof-of-concept trial. By - Jason D Roberts MD, Prof George A Wells PhD, Prof M...View full resource at thelancet.com

  • View Related
  • Share

Most Recently Shared on May 4, 2012 at 7:50 pm By:

Genetics_Wisdom Genetics OW OW Health

[Articles] Point-of-care genetic testing for personalisation of antiplatelet treatment (RAPID GENE): a prospecti... http://t.co/heUPAiHl

4 weeks ago...

Towards an optimum strategy in rheumatoid arthritis : The Lancet

thelancet.com — “Towards an optimum strategy in rheumatoid arthritis. By - Paul Emery, Maya H BuchView full resource at thelancet.com

  • View Related
  • Share

Most Recently Shared on May 4, 2012 at 6:36 pm By:

RA_Wisdom OrganizedWisdom RA OW Health

[Comment] Towards an optimum strategy in rheumatoid arthritis: The outcome for patients with rheumatoid arthriti... http://t.co/aSjoFZef

4 weeks ago...

Conventional combination treatment versus biological treatment in methotrexate-refractory early rheumatoid arthritis: 2 year follow-up of the randomised, non-blinded, parallel-group Swefot trial : The Lancet

thelancet.com — “Conventional combination treatment versus biological treatment in methotrexate-refractory early rheumatoid arthritis: 2 year follow-up of the randomised, non-blinded, parallel-group Swefot trial. B...View full resource at thelancet.com

  • View Related
  • Share

Most Recently Shared on May 4, 2012 at 6:36 pm By:

RA_Wisdom OrganizedWisdom RA OW Health

[Articles] Conventional combination treatment versus biological treatment in methotrexate-refractory early rheum... http://t.co/eQiIWYgz

4 weeks ago...

Minimally Invasive Procedure For Oesophageal Cancer Shows Promise

medicalnewstoday.com — “Patients with oesophageal cancer could gain substantial benefit from minimally invasive procedure.A new study published Online First in The Lancet reveals that removingView full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on May 1, 2012 at 7:05 pm By:

mnt_cancer MNT Cancer News Health News

Minimally Invasive Procedure For Oesophageal Cancer Shows Promise http://t.co/ovC47fO4 #cancer

1 month ago...

Ipilimumab and a poxviral vaccine targeting prostate-specific antigen in metastatic castration-resistant prostate cancer: a phase 1 dose-escalation trial : The Lancet Oncology

thelancet.com — “Ipilimumab and a poxviral vaccine targeting prostate-specific antigen in metastatic castration-resistant prostate cancer: a phase 1 dose-escalation trial. By - Ravi A Madan MD, Mahsa Mohebtash MD, ...View full resource at thelancet.com

  • View Related
  • Share

Most Recently Shared on May 1, 2012 at 5:37 pm By:

Cancer_PC Prostate Cancer OW OW Health

[Articles] Ipilimumab and a poxviral vaccine targeting prostate-specific antigen in metastatic castration-resist... http://t.co/L9G879WO

1 month ago...

The STAMPEDE trial and celecoxib: how to adapt? : The Lancet Oncology

thelancet.com — “The STAMPEDE trial and celecoxib: how to adapt?. By - Andrew J ArmstrongView full resource at thelancet.com

  • View Related
  • Share

Most Recently Shared on May 1, 2012 at 5:37 pm By:

Cancer_PC Prostate Cancer OW OW Health

[Comment] The STAMPEDE trial and celecoxib: how to adapt?: In The Lancet Oncology, Nicholas James and colleagues... http://t.co/UZhY4sWj

1 month ago...

Social media: how doctors can contribute : The Lancet

thelancet.com — “Social media: how doctors can contribute. By - The LancetView full resource at thelancet.com

  • View Related
  • Share

Most Recently Shared on April 30, 2012 at 2:33 pm By:

TheLancet The Lancet Medical Journal

Doctors should seize the opportunities provided by social networks to improve the health of their patients http://t.co/kPYIPsca

1 month ago...

Social media: how doctors can contribute : The Lancet

nrip.visibli.com — “Social media: how doctors can contribute : The LancetView full resource at nrip.visibli.com

  • View Related
  • Share

Most Recently Shared on April 28, 2012 at 1:00 am By:

The Lancet Technology: April, 2012 : The Lancet

thelancet.com — “The Lancet Technology: April, 2012. By - Niall BoyceView full resource at thelancet.com

  • View Related
  • Share

Most Recently Shared on April 27, 2012 at 11:10 pm By:

DrVes Ves Dimov, M.D. Internist, Allergist, Physician, and Doctor

Doctors and social media: “How to Stop Worrying and Learn to Love the Internet” http://t.co/JSXBL6QX

1 month ago...

Risky Behaviors In Teenagers Should Become Global Focus

medicalnewstoday.com — “According to a report published April 25 by The Lancet, with the global decline of childhood and adolescent mortality from infectious diseases, policymakers are shifting their focusView full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on April 27, 2012 at 5:05 pm By:

mnt_sexualhealt MNT Sexual Health Health News

Risky Behaviors In Teenagers Should Become Global Focus http://t.co/ts3gCtot #sexualhealth

1 month ago...

Advertisement